About the Targeted Therapies and Small Molecule Inhibitors Session
Targeted therapies and small molecule inhibitors are transforming cancer treatment by selectively attacking cancer cells while sparing healthy tissues. These therapies work by interfering with specific molecules involved in cancer growth and progression, such as tyrosine kinases and growth factor receptors. By focusing on molecular pathways unique to cancer cells, targeted therapies reduce systemic toxicity and improve treatment efficacy. Emerging small molecule inhibitors, often used in combination with other treatments, address resistance mechanisms and enhance therapeutic responses, offering hope for improved patient outcomes.
Topics Covered in Targeted Therapies and Small Molecule Inhibitors
Tyrosine Kinase Inhibitors
PARP Inhibitors
Growth Factor Receptors
Oncogene Addiction
Monoclonal Antibodies
Acquired Resistance
Related Scientific Sessions at CIOC 2027
Why Attend the Targeted Therapies and Small Molecule Inhibitors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Targeted Therapies and Small Molecule Inhibitors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Targeted Therapies and Small Molecule Inhibitors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Targeted Therapies and Small Molecule Inhibitors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Targeted Therapies and Small Molecule Inhibitors Conference 2027 — FAQs
What is the Targeted Therapies and Small Molecule Inhibitors track at CIOC 2027?
The Targeted Therapies and Small Molecule Inhibitors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Targeted Therapies and Small Molecule Inhibitors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Targeted Therapies and Small Molecule Inhibitors sessions?
Cancer researchers and clinicians, educators and students with an interest in Targeted Therapies and Small Molecule Inhibitors are all welcome — whether presenting or attending.
Can I present my research in the Targeted Therapies and Small Molecule Inhibitors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Targeted Therapies and Small Molecule Inhibitors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Targeted Therapies and Small Molecule Inhibitors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.